In contrast to the wide range of clinical manifestations accompanying GRN mutations, such as changes in behavior, executive functions, and/or language [137], the associated pathology, termed frontotemporal lobar degeneration (FTLD), is relatively homogeneous, with cortical atrophy tending to be most severe in the frontal lobes [120, 138]. This evidence concerns the gene GRN and frontotemporal dementia.